These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 20922193)
1. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. Mihalache F; Tantau M; Diaconu B; Acalovschi M J Gastrointestin Liver Dis; 2010 Sep; 19(3):285-90. PubMed ID: 20922193 [TBL] [Abstract][Full Text] [Related]
2. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806 [TBL] [Abstract][Full Text] [Related]
3. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice. Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885 [TBL] [Abstract][Full Text] [Related]
4. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic approach to the malignant tumors of the biliary tract. Mihalache F; Tantău M; Iancu C; Bodea R; Părău A; Acalovschi M Rom J Intern Med; 2010; 48(2):131-40. PubMed ID: 21428177 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Anderson C; Kim R Cancer Treat Rev; 2009 Jun; 35(4):322-7. PubMed ID: 19147294 [TBL] [Abstract][Full Text] [Related]
7. Surgical therapy for hiliar cholangiocarcinoma: analysis of 198 cases. Zhang BH; Cheng QB; Luo XJ; Zhang YJ; Jiang XQ; Zhang BH; Yi B; Yu WL; Wu MC Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):278-82. PubMed ID: 16698591 [TBL] [Abstract][Full Text] [Related]
8. [Current management and prognosis of intrahepatic cholangiocarcinoma in France]. Borie F; Niampa H; Bouvier AM; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B Gastroenterol Clin Biol; 2009; 33(10-11):971-6. PubMed ID: 19647386 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic management of hilar cholangiocarcinoma--one stent or two? Hatfield AR Bildgebung; 1995 Oct; 62 Suppl 2():53-4. PubMed ID: 8589585 [No Abstract] [Full Text] [Related]
10. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899 [TBL] [Abstract][Full Text] [Related]
11. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760 [TBL] [Abstract][Full Text] [Related]
12. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy. Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in cholangiocarcinomas. Ortner MA Best Pract Res Clin Gastroenterol; 2004 Feb; 18(1):147-54. PubMed ID: 15123089 [TBL] [Abstract][Full Text] [Related]
14. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus. Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991 [TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702 [TBL] [Abstract][Full Text] [Related]
17. Cholangiocarcinoma: an endoscopist's perspective. Atiq M; Javle M; Dang S; Lee JH Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):601-11. PubMed ID: 20932145 [TBL] [Abstract][Full Text] [Related]
18. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment. Demols A; Maréchal R; Devière J; Van Laethem JL Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701 [TBL] [Abstract][Full Text] [Related]
19. Surgical procedure and prognosis of hilar cholangiocarcinoma. Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688 [TBL] [Abstract][Full Text] [Related]
20. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre. Singal AG; Rakoski MO; Salgia R; Pelletier S; Welling TH; Fontana RJ; Lok AS; Marrero JA Aliment Pharmacol Ther; 2010 Mar; 31(6):625-33. PubMed ID: 20003093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]